Why the study?
Extravascular ICD is contraindicated in patients with prior sternotomy due to adhesion-related risks, but implantation in collaboration with Cardiac Surgery may be justifiable in select patients with retrosternal adhesions.
EV-ICD implantation may be feasible in select patients with retrosternal adhesions when performed in collaboration with cardiac surgery, despite being generally contraindicated.
May warrant consideration in select adhesion cases when alternatives are limited; leaves open need for prospective validation.
Extravascular ICD (EV-ICD) is distinct from transvenous and subcutaneous ICD types in that its implantation is extracardiac but intrathoracic, utilizing a substernal position. EV-ICD is contraindicated in patients with prior sternotomy, as the resultant retrosternal adhesions pose risks to mediastinal structures during the tunneling for placement of the lead.1 However, the implantation risks of EV-ICD in collaboration with Cardiac Surgery may be justifiable in select patients with retrosternal adhesions when alternative options are disadvantageous.
No takes yet. Share an insight, caveat, or question.
Douglas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: